Lamivudine/raltegravir: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 17:13, 17 March 2025
Lamivudine/raltegravir is a medication used in the treatment of HIV/AIDS. It is a combination of two antiretroviral drugs, lamivudine and raltegravir, which work together to prevent the virus from replicating in the body.
Composition[edit]
The medication is composed of two active ingredients: lamivudine and raltegravir. Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI), which works by blocking the action of an enzyme called reverse transcriptase, which the virus uses to replicate itself. Raltegravir is an integrase inhibitor, which works by blocking another enzyme that the virus uses to insert its genetic material into the cells it infects.
Uses[edit]
Lamivudine/raltegravir is used in the treatment of HIV/AIDS. It is typically used in combination with other antiretroviral drugs as part of a regimen known as antiretroviral therapy (ART). This therapy is designed to reduce the amount of virus in the body, slow the progression of the disease, and improve the quality of life of people living with HIV/AIDS.
Side Effects[edit]
Like all medications, lamivudine/raltegravir can cause side effects. These may include nausea, diarrhea, and headache. In rare cases, it can cause more serious side effects, such as liver problems or a severe skin reaction. Patients should contact their healthcare provider if they experience any unusual or severe side effects.
Interactions[edit]
Lamivudine/raltegravir can interact with other medications, which can affect how it works or increase the risk of side effects. It is important for patients to tell their healthcare provider about all the medications they are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements.
Precautions[edit]
Before starting treatment with lamivudine/raltegravir, patients should discuss their medical history with their healthcare provider. This includes any history of liver disease, kidney disease, or other medical conditions. Patients should also inform their healthcare provider if they are pregnant, planning to become pregnant, or breastfeeding.
